Adam J. Chill serves as Executive at CB Pharma Acquisition Corp., where they oversee executive responsibilities. Since joining the company, Adam J. Chill has executed 10 insider transactions totaling $4, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 30, 2025 involved selling 4 shares valued at $4.
Adam J. Chill currently holds 375 shares of CB Pharma Acquisition Corp. (CNLM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam J. Chill has been a net seller of CNLM stock. They have purchased $0 and sold $4 worth of shares.
Adam J. Chill's most recent insider trade was on Dec 30, 2025, when they sold 4 shares at $0.95 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 29, 2022 | MBIO | $0 | Award | 71,664 | $N/A | Discretionary |
| Jun 28, 2021 | MBIO | $0 | Award | 13,774 | $N/A | Discretionary |
| Jul 14, 2020 | MBIO | $0 | Award | 16,611 | $N/A | Discretionary |
| Aug 28, 2019 | MBIO | $0 | Award | 13,812 | $N/A | Discretionary |
| Nov 12, 2018 | MBIO | $4.8K | Award | 1,000 | $4.85 | Discretionary |
| Nov 8, 2018 | MBIO | $10.7K | Award | 2,000 | $5.34 | Discretionary |
| Jun 14, 2018 | MBIO | $0 | Award | 10,000 | $N/A | Discretionary |
| May 20, 2016 | CNLM | $0 | Sale | 10,000 | $N/A | Discretionary |